FDA clearance
Colin Kerr
Published: Thursday, February 1, 2018
Topcon Medical Systems has announced that its PASCAL Laser has received FDA clearance (K171488) to offer Pattern Scanning Laser Trabeculoplasty (PSLT) for the reduction of intraocular pressure (IOP) associated with glaucoma.
PSLT is an advanced tissue-sparing laser treatment for reducing intraocular pressure in open-angle glaucoma.
“The availability of PSLT, offers now a clinically-proven glaucoma treatment technology to ophthalmologists in the US,” said Robert Gibson, Vice President, Eye Care Global Marketing, Topcon Corporation.
"Globally, we’ve seen success with the Streamline PSLT application and believe glaucoma specialists and comprehensive ophthalmologists in the United States will find this technology a useful addition to their treatment armamentarium.” http://global.topcon.com
Latest Articles
Glaucoma Treatment Under Pressure
New techniques and technologies add to surgeons’ difficult decisions
Outside the Box, Inside the Pipeline
Researchers are tackling glaucoma diagnosis and treatment from all sides.
The EHDS Is Ready for the Green Light
If proposal is approved, Europe could see better access to, and exchange and use of, health data.
From Lab to Life: Corneal Repair Goes Cellular
Long-awaited cellular therapies for corneal endothelial disease enter the clinic.
Balancing Innovation and Safety
Ensuring access to advanced cell therapies amid regulatory overhaul.
With Eyes on Its Future, ESCRS Celebrates Its Past
Winter Meeting offers opportunities to experiment with new concepts and formats.
Best of ESCRS Winter Meeting 2024
Following the New Generation
EDOF IOLs an option for eyes with mild comorbidities, showing potential in mini-monovision strategies.
Refocus on Multifocals
Trifocal IOLs continue to improve as consensus grows regarding indications and contraindications.
Common Myths in Presbyopia Correction
Patient education key to satisfaction with refractive IOLs.